These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21384281)

  • 1. Proteomic analysis of soft tissue sarcoma.
    Suehara Y
    Int J Clin Oncol; 2011 Apr; 16(2):92-100. PubMed ID: 21384281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global protein-expression analysis of bone and soft tissue sarcomas.
    Kawai A; Kondo T; Suehara Y; Kikuta K; Hirohashi S
    Clin Orthop Relat Res; 2008 Sep; 466(9):2099-106. PubMed ID: 18535868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas.
    Suehara Y; Kondo T; Fujii K; Hasegawa T; Kawai A; Seki K; Beppu Y; Nishimura T; Kurosawa H; Hirohashi S
    Proteomics; 2006 Aug; 6(15):4402-9. PubMed ID: 16807943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of biomarkers for osteosarcoma by proteomics approaches.
    Suehara Y; Kubota D; Kikuta K; Kaneko K; Kawai A; Kondo T
    Sarcoma; 2012; 2012():425636. PubMed ID: 23226966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of proteomics of soft tissue sarcomas.
    Kondo T
    Expert Rev Proteomics; 2017 Dec; 14(12):1131-1140. PubMed ID: 29039718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
    Tang S; Wang Y; Luo R; Fang R; Liu Y; Xiang H; Ran P; Tong Y; Sun M; Tan S; Huang W; Huang J; Lv J; Xu N; Yao Z; Zhang Q; Xu Z; Yue X; Yu Z; Akesu S; Ding Y; Xu C; Lu W; Zhou Y; Hou Y; Ding C
    Nat Commun; 2024 Feb; 15(1):1381. PubMed ID: 38360860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic research in sarcomas - current status and future opportunities.
    Burns J; Wilding CP; L Jones R; H Huang P
    Semin Cancer Biol; 2020 Apr; 61():56-70. PubMed ID: 31722230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue sample preparation for biomarker discovery.
    Suehara Y; Kubota D; Saito T
    Methods Mol Biol; 2013; 1002():13-23. PubMed ID: 23625391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of TEIF protein in soft tissue tumors and its significance].
    Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
    Chadha M; Huang PH
    Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
    Hasegawa T
    Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
    Noujaim J; Thway K; Sheri A; Keller C; Jones RL
    Int J Surg Pathol; 2016 Feb; 24(1):5-15. PubMed ID: 26399578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of soft tissue tumors by fine-needle aspiration with combined cytopathology and ancillary techniques.
    Sápi Z; Antal I; Pápai Z; Szendröi M; Mayer A; Jakab K; Pajor L; Bodó M
    Diagn Cytopathol; 2002 Apr; 26(4):232-42. PubMed ID: 11933269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities.
    Serra M; Scotlandi K; Manara MC; Maurici D; Benini S; Sarti M; Nini G; Barbanti-Brodano G; Baldini N
    Cytotechnology; 1996; 19(3):253-6. PubMed ID: 8862015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intense accumulation of 18F-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors.
    Park JH; Park EK; Kang CH; Kim CH; Choe JG; Noh W
    Ann Nucl Med; 2009 Dec; 23(10):887-9. PubMed ID: 19862481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
    Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
    Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in sarcomas.
    Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.
    Sato H; Hasegawa T; Abe Y; Sakai H; Hirohashi S
    Hum Pathol; 1999 Nov; 30(11):1344-9. PubMed ID: 10571515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
    Isfort I; Elges S; Cyra M; Berthold R; Renner M; Mechtersheimer G; Åman P; Larsson O; Ratner N; Hafner S; Simmet T; Schliemann C; Rossig C; Dirksen U; Grünewald I; Wardelmann E; Huss S; Hartmann W; Trautmann M
    Sci Rep; 2019 Dec; 9(1):19704. PubMed ID: 31873172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.